AC Immune SA ACIU:NASDAQ

RT Quote | NASDAQ | USD
Last | 4:00 PM EDT
3.33quote price arrow down-0.14 (-4.03%)
Volume
30,848
52 week range
2.06 - 12.61
Loading...
  • Open3.45
  • Day High3.55
  • Day Low3.32
  • Prev Close3.47
  • 52 Week High12.61
  • 52 Week High Date08/31/21
  • 52 Week Low2.06
  • 52 Week Low Date06/16/22

Key Stats

  • Market Cap278.22M
  • Shares Out83.55M
  • 10 Day Average Volume0.04M
  • Dividend-
  • Dividend Yield-
  • Beta0.67
  • YTD % Change-32.73

KEY STATS

  • Open3.45
  • Day High3.55
  • Day Low3.32
  • Prev Close3.47
  • 52 Week High12.61
  • 52 Week High Date08/31/21
  • 52 Week Low2.06
  • 52 Week Low Date06/16/22
  • Market Cap278.22M
  • Shares Out83.55M
  • 10 Day Average Volume0.04M
  • Dividend-
  • Dividend Yield-
  • Beta0.67
  • YTD % Change-32.73

RATIOS/PROFITABILITY

  • EPS (TTM)-0.98
  • P/E (TTM)-3.40
  • Fwd P/E (NTM)-4.78
  • EBITDA (TTM)-84.44M
  • ROE (TTM)-38.60%
  • Revenue (TTM)0.00
  • Gross Margin (TTM)-
  • Net Margin (TTM)-7,544.60%
  • Debt To Equity (MRQ)1.30%

EVENTS

  • Earnings Date11/07/2022(est)
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On AC Immune SA

There is no recent news for this security.

Profile

MORE
AC Immune SA is a Switzerland-based clinical-stage biopharmaceutical company. The Company focuses on precision medicine for neurodegenerative diseases. It designs, discovers and develops therapeutic, as well as diagnostic products for prevention, diagnosis and treatment of diseases caused by misfolding proteins. Its SupraAntigen and Morphomer technology platforms to create antibodies, small molecules and vaccines designed to address a broad range of neurodegenerative...
Douglas Williams Ph.D.
Independent Chairman of the Board
Andrea Pfeifer Ph.D.
Chief Executive Officer, Co-Founder, Director
Piergiorgio Donati
Chief Technical Operations Officer
Joerg Hornstein
Chief Financial Officer
Address
EPFL Innovation Park, Building B
Lausanne
1015
Switzerland

Top Peers

SYMBOLLASTCHG%CHG
VKTX
Viking Therapeutics Inc
3.73-0.04-1.06%
OMIC
Singular Genomics Systems Inc
3.20-0.82-20.40%
OTLK
Outlook Therapeutics Inc
1.21-0.02-1.63%
KRON
Kronos Bio Inc
4.54-0.31-6.39%
CMPX
Compass Therapeutics Inc.
3.00-0.02-0.66%